WELLINGTON MANAGEMENT GROUP LLP - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 82 filers reported holding GLYCOMIMETICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q3 2020$11,289,000
-34.1%
3,677,329
-19.3%
0.00%
-50.0%
Q2 2020$17,139,000
+55.6%
4,558,449
-5.7%
0.00%
+33.3%
Q1 2020$11,016,000
-43.8%
4,831,896
+30.4%
0.00%
-25.0%
Q4 2019$19,605,000
+17.9%
3,705,977
-3.9%
0.00%0.0%
Q3 2019$16,625,000
-70.7%
3,857,264
-19.0%
0.00%
-69.2%
Q2 2019$56,768,000
-8.2%
4,762,331
-4.1%
0.01%
-7.1%
Q1 2019$61,861,000
+22.8%
4,964,693
-6.7%
0.01%
+7.7%
Q4 2018$50,373,000
-38.3%
5,319,265
-6.2%
0.01%
-23.5%
Q3 2018$81,695,000
-9.4%
5,673,374
+1.4%
0.02%
-15.0%
Q2 2018$90,206,000
-4.0%
5,592,390
-3.4%
0.02%
-4.8%
Q1 2018$93,930,000
+56.3%
5,787,454
+61.7%
0.02%
+61.5%
Q4 2017$60,081,000
+22.9%
3,578,422
+2.4%
0.01%
+18.2%
Q3 2017$48,893,000
+27.0%
3,494,870
+1.3%
0.01%
+22.2%
Q2 2017$38,507,000
+120.5%
3,450,538
+7.3%
0.01%
+125.0%
Q1 2017$17,467,000
+2.3%
3,216,751
+14.9%
0.00%0.0%
Q4 2016$17,079,000
-13.5%
2,799,917
+1.3%
0.00%
-20.0%
Q3 2016$19,754,000
+0.3%
2,762,807
+1.9%
0.01%0.0%
Q2 2016$19,704,000
+23.9%
2,710,310
+1.5%
0.01%
+25.0%
Q1 2016$15,907,000
+5.9%
2,669,015
+1.7%
0.00%0.0%
Q4 2015$15,016,000
+2.2%
2,625,363
+0.1%
0.00%0.0%
Q3 2015$14,687,000
-29.5%
2,622,738
+0.1%
0.00%
-20.0%
Q2 2015$20,829,000
-4.4%
2,619,980
+0.0%
0.01%
-16.7%
Q1 2015$21,794,000
+16.5%
2,619,388
+0.8%
0.01%
+20.0%
Q4 2014$18,713,000
+3.5%
2,599,011
-0.2%
0.01%0.0%
Q3 2014$18,081,000
-11.0%
2,605,408
+8.1%
0.01%0.0%
Q2 2014$20,310,000
-49.2%
2,409,246
-1.5%
0.01%
-54.5%
Q1 2014$39,951,0002,446,4380.01%
Other shareholders
GLYCOMIMETICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,000,000$4,500,0000.69%
Artal Group S.A. 8,589,064$12,8840.55%
NEA Management Company, LLC 4,764,440$7,146,6600.55%
BVF INC/IL 9,544,262$14,316,3930.39%
Intellectus Partners, LLC 61,975$92,9630.03%
ACUTA CAPITAL PARTNERS, LLC 27,500$41,2500.03%
Sargent Investment Group, LLC 58,000$87,0000.02%
GSA CAPITAL PARTNERS LLP 93,785$1410.01%
AXA S.A. 1,625,698$2,438,5470.01%
XTX Topco Ltd 32,722$49,0830.01%
View complete list of GLYCOMIMETICS INC shareholders